Microwave therapy of benign prostatic hyperplasia
Goldfarb, B.; Bartkiw, T.; Trachtenberg, J.
Urologic Clinics of North America 22(2): 431-439
1995
ISSN/ISBN: 0094-0143 PMID: 7539188 Document Number: 443285
Thermotherapy of the prostate proves to be a safe and effective treatment for patients with symptomatic prostatism secondary to BPH. Present treatment regimens yield results and side effects intermediate between drug therapy and prostatectomy. Future enhancements of the thermotherapy technique are likely to improve its results to the level of surgery.
Document emailed within 1 workday
Related Documents
Jonas, U.; Melchior, H.; Rübben, H. 1998: Recommendations for billing alternative therapy of benign prostatic hyperplasia. Laser therapy of benign prostatic hyperplasia Der Urologe. Ausg. a 37(1): 110-111Murayama, K.; Hisada, K. 2000: Transurethral microwave thermotherapy for benign prostatic hyperplasia Hinyokika Kiyo. Acta Urologica Japonica 46(11): 799-802
Ramsey, E.W. 1995: Transurethral microwave thermotherapy in the treatment of benign prostatic hyperplasia Surgical Technology International Iv: 261-265
Ekman, P. 1992: Drug therapy of benign prostatic hyperplasia Lakartidningen 89(45): 3803-3804
Trinkler, F.B. 1997: Therapy of benign prostatic hyperplasia: terazosin or finasteride? Praxis 86(34): 1305-1306
Madersbacher, S.; Marberger, M. 1996: Minimal invasive therapy of benign prostatic hyperplasia Wiener Medizinische Wochenschrift 146(8): 169-175
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Effert, P.; Ackermann, R. 1992: Clinical manifestations and indications for therapy of benign prostatic hyperplasia Der Urologe. Ausg. a 31(3): 135-141
Hanus, M.; Matousková, M. 1993: Antiestrogens (tamoxifen) in the alternative therapy of benign prostatic hyperplasia Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 72(7): 316-318
Savage, S.J..; Spungen, A.M..; Galea, G.; Britanico, J.; Vapnek, J.M.. 1998: Combination medical therapy for symptomatic benign prostatic hyperplasia Canadian Journal of Urology 5(3): 578-584
Drsata, J. 2002: Enzyme inhibition in the drug therapy of benign prostatic hyperplasia Casopis Lekaru Ceskych 141(20): 630-635
Takayama, T.; Arakawa, I.; Kakihara, H.; Tachibana, K.; Ozono, S. 2012: Pharmacoeconomic evaluation of combination therapy with dutasteride and α1 blocker for treatment of benign prostatic hyperplasia in Japan Hinyokika Kiyo. Acta Urologica Japonica 58(2): 61-69
Spivak, L.G.; Lokshin, K.L.; Vinarov, A.Z. 2015: Review of Clinical Studies on Combination Therapy of 5α-Reductase Inhibitors and Α1-Blockers in Patients with Benign Prostatic Hyperplasia Urologiia 2015(4): 125-133
Larcher, P.; Borroni, G.; Begani, A.; Franch, P.; Grisotto, M. 2005: The use of vesical irrigation system dual pump Endo FMS urology in the endoscopic therapy of benign prostatic hyperplasia Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 77(2): 139-140
Sivkov, A.V.; Egorov, A.A.; Romikh, V.V.; Surikov, V.N. 2002: Urodynamic criteria of predicting efficacy of therapy with alpha1-adrenergic blockaders in patients with benign prostatic hyperplasia Urologiia 2002(5 Suppl): 13-22
Brannen, G.E.; Coffey, D.S. 1977: Tumor-specific immunity in patients with prostatic adenocarcinoma or benign prostatic hyperplasia Cancer Treatment Reports 61(2): 211-216
Gu, F. 2000: Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China Chinese Medical Journal 113(4): 299-302
Kletscher, B.A.; Oesterling, J.E. 1995: Prostatic stents. Current perspectives for the management of benign prostatic hyperplasia Urologic Clinics of North America 22(2): 423-430
Blanc, M.; Sacrini, A.; Avogadro, A.; Gattamorta, M.; Lazzerini, F.; Gattoni, F.; Cretti, F. 1998: Prostatic volume: suprapubic versus transrectal ultrasonography in the control of benign prostatic hyperplasia La Radiologia Medica 95(3): 182-187
Pretlow, T.G.; Whitehurst, G.B.; Pretlow, T.P.; Hunt, R.S.; Jacobs, J.M.; McKenzie, D.R.; McDaniel, H.G.; Hall, L.M.; Bradley, E.L. 1982: Decrease in creatine kinase in human prostatic carcinoma compared to benign prostatic hyperplasia Cancer Research 42(11): 4842-4848